FFA
CYTK icon

Farther Finance Advisors’s Cytokinetics CYTK Stock Holding History

Farther Finance Advisors’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$46.9K Buy
712
+34
+5% +$2.59K ﹤0.01% 3476
2026
Q2 		$58K Sell
678
-431
-39% -$30.9K ﹤0.01% 3130
2026
Q1 		$73.9K Buy
1,109
+2
+0.2% +$127 ﹤0.01% 2733
2025
Q4 		$70.3K Sell
1,107
-8
-0.7% -$498 ﹤0.01% 2576
2025
Q3 		$61.3K Buy
1,115
+453
+68% +$18.7K ﹤0.01% 2330
2025
Q2 		$21.9K Sell
662
-216
-25% -$7.51K ﹤0.01% 2626
2025
Q1 		$32.9K Sell
878
-137
-13% -$6.3K ﹤0.01% 2119
2024
Q4 		$47.7K Sell
1,015
-64
-6% -$3.32K ﹤0.01% 1680
2024
Q3 		$57K Sell
1,079
-181
-14% -$10.1K ﹤0.01% 1580
2024
Q2 		$68.9K Buy
1,260
+24
+2% +$1.45K ﹤0.01% 1274
2024
Q1 		$90.3K Buy
1,236
+65
+6% +$5.03K 0.01% 976
2023
Q4 		$97.8K Sell
1,171
-133
-10% -$4.82K 0.01% 810
2023
Q3 		$38.4K Buy
1,304
+52
+4% +$1.73K 0.01% 860
2023
Q2 		$40.8K Sell
1,252
-476
-28% -$17.6K 0.01% 737
2023
Q1 		$60.8K Buy
+1,728
New +$70.5K 0.02% 548

Other funds holding CYTK

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VC
Veracity Capital Atlanta, Georgia $372M AUM 32.95% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

Farther Finance Advisors's CYTK Position: Q3 2026 in Review

Farther Finance Advisors increased its Cytokinetics (CYTK) stake by 5% in Q3 2026, buying an estimated $2.59K and bringing the position to 712 shares worth $46.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3476.

Farther Finance Advisors first reported a position in CYTK in Q1 2023 and has held it in 15 quarters since. The position peaked at $97.8K in Q4 2023. 13 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Farther Finance Advisors held 712 shares of Cytokinetics worth $46.9K as of Q3 2026.
  • Farther Finance Advisors bought 34 Cytokinetics shares in Q3 2026, an estimated $2.59K.
  • Cytokinetics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3476 holding.
  • Farther Finance Advisors first reported a position in Cytokinetics in Q1 2023 and has held it in 15 quarters since.
  • Farther Finance Advisors's Cytokinetics position peaked at $97.8K in Q4 2023.
  • 13 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.